These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9323262)

  • 1. Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms.
    Tiling R; Khalkhali I; Sommer H; Moser R; Meyer G; Willemsen F; Pfluger T; Tatsch K; Hahn K
    Eur J Nucl Med; 1997 Oct; 24(10):1221-9. PubMed ID: 9323262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
    Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
    Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography.
    Tiling R; Khalkhali I; Sommer H; Linke R; Moser R; Willemsen F; Pfluger T; Tatsch K; Hahn K
    Nucl Med Commun; 1998 Jan; 19(1):55-62. PubMed ID: 9515547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography.
    Tiling R; Kessler M; Untch M; Sommer H; Linke R; Hahn K
    Eur J Radiol; 2005 Feb; 53(2):206-12. PubMed ID: 15664284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions.
    Tiling R; Sommer H; Pechmann M; Moser R; Kress K; Pfluger T; Tatsch K; Hahn K
    J Nucl Med; 1997 Jan; 38(1):58-62. PubMed ID: 8998151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging.
    Tiling R; Tatsch K; Sommer H; Meyer G; Pechmann M; Gebauer K; Münzing W; Linke R; Khalkhali I; Hahn K
    J Nucl Med; 1998 May; 39(5):849-56. PubMed ID: 9591588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging.
    Palmedo H; Grünwald F; Bender H; Schomburg A; Mallmann P; Krebs D; Biersack HJ
    Eur J Nucl Med; 1996 Aug; 23(8):940-6. PubMed ID: 8753683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer.
    Bagni B; Franceschetto A; Casolo A; De Santis M; Bagni I; Pansini F; Di Leo C
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1383-8. PubMed ID: 12910383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary role of adjunctive breast magnetic resonance imaging and scintimammography in patients of all ages undergoing breast cancer surgery.
    Howarth D; Slater S; Lau P; Booker J; Clark D; Sillar R
    Australas Radiol; 2005 Aug; 49(4):289-97. PubMed ID: 16026435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between 99mTc-sestamibi scintimammography and X-ray mammography in the characterization of clusters of microcalcifications: a prospective long-term study.
    Grosso M; Chiacchio S; Bianchi F; Traino C; Marini C; Cilotti A; Manca G; Volterrani D; Roncella M; Rampin L; Marzola MC; Rubello D; Mariani G
    Anticancer Res; 2009 Oct; 29(10):4251-7. PubMed ID: 19846982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
    Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C
    Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of early and double phase 99Tcm-sestamibi scintimammography in the diagnosis of breast cancer.
    Paz A; Melloul M; Cytron S; Koren R; Ohana G; Michalevich D; Gal R; Wolloch Y
    Nucl Med Commun; 2000 Apr; 21(4):341-8. PubMed ID: 10845222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography.
    Helbich TH; Becherer A; Trattnig S; Leitha T; Kelkar P; Seifert M; Gnant M; Staudenherz A; Rudas M; Wolf G; Mostbeck GH
    Radiology; 1997 Feb; 202(2):421-9. PubMed ID: 9015068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 99mTc-sestamibi scintimammography and dynamic MR imaging as adjuncts to mammography in the diagnosis of breast cancer.
    Boné B; Wiberg MK; Szabó BK; Szakos A; Danielsson R
    Acta Radiol; 2003 Jan; 44(1):28-34. PubMed ID: 12630995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can scintimammography reduce "unnecessary" biopsies?
    Flanagan DA; Gladding SB; Lovell FR
    Am Surg; 1998 Jul; 64(7):670-2; discussion 673. PubMed ID: 9655280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.